Hana Biosciences, Inc. – Trademark Portfolio
Entity Type: 03
Hana Biosciences, Inc. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MARQIBO. The owner is based in South San Francisco, CA.
7000 Shoreline Court, Suite 370
South San Francisco, CA 94080
Showing of trademarks Trademarks
Trademark Classifications
Hana Biosciences, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Hana Biosciences, Inc. have?
Hana Biosciences, Inc. has 14 U.S. trademarks filed with the USPTO. Of these, 1 registered, 9 abandoned, 4 cancelled.
What trademark classes does Hana Biosciences, Inc. file in?
Hana Biosciences, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Hana Biosciences, Inc.'s most well-known trademarks?
Hana Biosciences, Inc.'s registered trademark portfolio includes well-known marks such as MARQIBO. These are among 1 currently registered trademark in the portfolio.
What is Hana Biosciences, Inc.'s trademark registration success rate?
Hana Biosciences, Inc. has a 7% trademark registration rate, with 1 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.